CTDSPL2 and acute myeloid leukemia: In AML, CTDSPL2 dephosphorylates the kinases STK35 and PDIK1L, facilitating their interaction, influencing the expression of genes related to amino acid biosynthesis and transport, and promoting the proliferation of AML cells [15].